MATERNUS-Kliniken AG (DE:MAK)

XETRA:MAK

MAK

MATERNUS-Kliniken AG

RESEARCH TOOLSreports

Want to see DE:MAK full AI Analyst Report?

MATERNUS-Kliniken AG (MAK) Price & Analysis

2 Followers

MAK Stock Chart & Stats

€0.98

-€0.01(-0.71%)

At close: Jan 08 4:00 PM EST

€0.98

-€0.01(-0.71%)

Day’s Range― - ―

52-Week Range€0.81 - €10.90

Previous CloseN/A

Volume132.00

Average Volume (3M)618.00

Market Cap

€19.29M

Enterprise Value€199.25M

Total Cash (Recent Filing)€2.18M

Total Debt (Recent Filing)€186.99M

Price to Earnings (P/E)―

Beta0.59

Next Earnings

Aug 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.72

Shares Outstanding20,970,000

10 Day Avg. Volume1,293

30 Day Avg. Volume618

Financial Highlights & Ratios

PEG Ratio-0.32

Price to Book (P/B)-0.27

Price to Sales (P/S)0.18

P/FCF Ratio1.92

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Stable Recurring Revenue ModelThe core business is long-term residential senior care with recurring reimbursements and resident fees. That payer mix and contract-like revenues tend to be stable and predictable, supporting durable cash inflows and operational planning over the next 2–6 months.

Positive Operating And Free Cash FlowConsistent positive operating cash flow and rising free cash flow in 2025 provide tangible liquidity to fund operations, maintenance capex and short-term obligations. Durable cash generation cushions operations and gives limited scope to manage near-term refinancing or working capital needs.

Improving Operating TrendReported results show narrowed losses and an improving operating trend from 2023 to 2025, indicating management has taken actions to cut costs or improve utilization. If sustained, this supports margin recovery and operational stability over the medium term.

Bears Say

Negative Shareholders' EquitySubstantial negative equity signals an impaired capital base and materially reduces financial flexibility. Over the coming months this elevates risk around covenants, refinancing access and counterparty confidence, constraining strategic options and capital investment.

High Leverage Relative To AssetsDebt exceeding reported assets creates structural leverage and refinancing vulnerability. Interest and amortization demand absorb cash flow, and with operating cash coverage roughly 0.11–0.15, the company has limited ability to delever quickly without asset sales or external capital.

Persistent Losses And Revenue ShockOngoing negative net margins combined with a steep ~33% revenue drop in 2025 weaken operating leverage and raise sustainability concerns. Unless revenue stabilizes, losses could persist, undermining cash flow improvements and increasing the chance of further balance sheet erosion.

MAK FAQ

What was MATERNUS-Kliniken AG’s price range in the past 12 months?

MATERNUS-Kliniken AG lowest stock price was €0.81 and its highest was €10.90 in the past 12 months.

What is MATERNUS-Kliniken AG’s market cap?

MATERNUS-Kliniken AG’s market cap is €19.29M.

When is MATERNUS-Kliniken AG’s upcoming earnings report date?

MATERNUS-Kliniken AG’s upcoming earnings report date is Aug 20, 2026 which is in 57 days.

How were MATERNUS-Kliniken AG’s earnings last quarter?

MATERNUS-Kliniken AG released its earnings results on Apr 30, 2026. The company reported -€0.563 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.563.

Is MATERNUS-Kliniken AG overvalued?

According to Wall Street analysts MATERNUS-Kliniken AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MATERNUS-Kliniken AG pay dividends?

MATERNUS-Kliniken AG does not currently pay dividends.

What is MATERNUS-Kliniken AG’s EPS estimate?

MATERNUS-Kliniken AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MATERNUS-Kliniken AG have?

MATERNUS-Kliniken AG has 20,970,000 shares outstanding.

What happened to MATERNUS-Kliniken AG’s price movement after its last earnings report?

MATERNUS-Kliniken AG reported an EPS of -€0.563 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8%.

Which hedge fund is a major shareholder of MATERNUS-Kliniken AG?

Currently, no hedge funds are holding shares in DE:MAK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MATERNUS-Kliniken AG Stock Smart Score

Underperform

Technicals

Top Smart Score Stocks >

Company Description

MATERNUS-Kliniken AG

Maternus-Kliniken AG oversees a network of facilities that includes retirement and nursing residences, rehabilitation centers, and a variety of specialized service companies. This enterprise primarily focuses on delivering geriatric care and medical rehabilitation services. Furthermore, it offers an extensive range of support options, such as emergency response systems, assisted living arrangements, and various care modalities including home care, residential care, temporary stays, and care for individuals with disabilities. Its services also encompass comprehensive rehabilitation and post-treatment programs. The company maintains roughly 23 establishments throughout Germany. Founded in 1877, Maternus-Kliniken AG's corporate headquarters are situated in Berlin, Germany.